The Marcus (MCS) Q4 2019 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2019 earnings summary
9 Nov, 2026Executive summary
FY2019 revenue reached a record $820.9M, up 16.1% YoY; operating income fell 18.0% to $68.2M and attributable net earnings declined 21.3% to $42.0M, pressured by a weaker film slate and Saint Kate costs.
The Movie Tavern acquisition lifted theatre revenue, while the Saint Kate conversion and weaker comparable theatre attendance weighed on earnings; the shareholder letter later described widespread temporary COVID-19 closures and cash-conservation actions.
Financial highlights
Revenue $820.9M vs. $707.1M; operating income $68.2M vs. $83.2M; attributable net earnings $42.0M vs. $53.4M; diluted EPS $1.35 vs. $1.86.
Operating cash flow was $141.5M vs. $137.4M; cash capital expenditures were $64.1M, and capital expenditures, acquisitions and joint-venture investments totaled $94.2M.
FY2019 included $2.5M of Movie Tavern acquisition/preopening costs, $6.8M of Saint Kate preopening and startup costs, and a $1.9M theatre impairment charge.
Outlook and guidance
FY2020 is a 53-week year; the extra week, including the traditionally strong Christmas-to-New-Year theatre period, is expected to benefit results, though comparable benefits are not assured.
FY2020 cash capital expenditures were forecast at $65M–$85M, excluding unidentified acquisitions; theatre spending was expected at $45M–$60M and hotels/resorts at $20M–$25M.
FY2020 effective tax rate was expected at 24%–26%, depending partly on excess share-based compensation tax benefits; interest expense was not expected to change materially.
After the letter’s March 31 date, theatres were temporarily closed, most hotels and restaurants were temporarily closed, and expenses were being cut and cash conserved; the ultimate financial impact was uncertain.
Latest events from The Marcus
- FY2023 rebounded across theatres and hotels, while film supply clouds the FY2024 theatre outlook.MCS
Q4 2023 - FY22 recovery lifted EBITDA, but film supply and business travel remain constraints.MCS
Q4 2022 - Recovery lifted FY2021 Adjusted EBITDA to $35.1M, but the net loss remained $43.3M.MCS
Q4 2021 - Pandemic closures drove a $124.8M loss, with recovery hinging on reopening and demand.MCS
Q4 2020 - Record revenue and operating income; Movie Tavern expands the footprint as FY2019 investment rises.MCS
Q4 2018 - Record earnings and theatre outperformance powered growth amid acquisition-led expansion.MCS
Q4 2016 - Record FY2017 results, boosted by theatre growth and a one-time tax benefit.MCS
Q4 2017 - Record revenue and segment growth; adjusted earnings rose nearly 12%.MCS
Q4 2015 - F2014 earnings rose on stronger theatres and hotels, with elevated investment and market risks ahead.MCS
Q4 2014